Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

MARKER' CEO,P.H. the B of D... Baylor researchers, mayo researchers, and a few supporting hospitals and clinics hold the data, the possible results, and control any and all releases.

I await the year end financials and particularly the M D & A section.

Just guessing but what has emerged as a possibility might suggest another application for " Fast track " and "Orphan drug status as was granted under TPIV.

Additionally, I would appreciate a narrative on how many different cancers this drug might have applications.

The trading community certainly has developed an interest.. I am confident that with information such as we anticipate, my $7.88 break even will be surpassed nearly 5 times over..

What thoughts in these areas have you?